Prevalence of symptoms suggestive of extra-oesophageal reflux in a general practice population in the UK
- PMID: 19214865
- DOI: 10.1080/14015430902735847
Prevalence of symptoms suggestive of extra-oesophageal reflux in a general practice population in the UK
Abstract
Unlike gastro-oesophageal reflux, extra-oesophageal reflux (EOR) is not necessarily associated with heartburn. The potential prevalence of EOR in general practice in the UK using the Reflux Symptom Index (RSI) questionnaire was determined. A total of 1152 patients attending a GP surgery for routine conditions completed the RSI questionnaire: 26.5% had an RSI score >10, regarded as a clinically significant score for EOR; 29% of patients with a significant RSI score rated the impact of heartburn in the previous month as zero. Significant numbers of patients presenting to GPs have high RSI scores suggesting significant reflux. Many patients likely to have EOR do not experience classical heartburn. This might explain why some GPs may not attribute common symptoms affecting the throat to gastric reflux.
Similar articles
-
Effect of sex on symptoms associated with gastroesophageal reflux.Arch Surg. 2011 Oct;146(10):1164-9. doi: 10.1001/archsurg.2011.248. Arch Surg. 2011. PMID: 22006875
-
Association of heartburn and laryngopharyngeal symptoms with endoscopic reflux esophagitis, smoking, and drinking.Otolaryngol Head Neck Surg. 2009 Aug;141(2):264-71. doi: 10.1016/j.otohns.2009.05.017. Otolaryngol Head Neck Surg. 2009. PMID: 19643263
-
[The enhancement of the efficacy of early diagnostics of laryngopharyngeal reflux].Vestn Otorinolaringol. 2015;(1):60-62. doi: 10.17116/otorino201580160-62. Vestn Otorinolaringol. 2015. PMID: 25909678 Russian.
-
Review article: gastro-oesophageal reflux disease -- how wide is its span?Aliment Pharmacol Ther. 2004 Oct;20 Suppl 5:27-37; discussion 38-9. doi: 10.1111/j.1365-2036.2004.02134.x. Aliment Pharmacol Ther. 2004. PMID: 15456461 Review.
-
Review article: Gastro-oesophageal reflux disease--application of the concept of complete remission.Aliment Pharmacol Ther. 2007 Dec;26 Suppl 2:13-6. doi: 10.1111/j.1365-2036.2007.03493.x. Aliment Pharmacol Ther. 2007. PMID: 18081644 Review.
Cited by
-
Gaviscon® Advance alone versus co-prescription of Gaviscon® Advance and proton pump inhibitors in the treatment of laryngopharyngeal reflux.Eur Arch Otorhinolaryngol. 2018 Oct;275(10):2515-2521. doi: 10.1007/s00405-018-5079-0. Epub 2018 Jul 30. Eur Arch Otorhinolaryngol. 2018. PMID: 30062580
-
Psychosocial burden in patients with chronic laryngopharyngeal symptoms with and without pathologic acid reflux.Neurogastroenterol Motil. 2024 Sep;36(9):e14852. doi: 10.1111/nmo.14852. Epub 2024 Jun 24. Neurogastroenterol Motil. 2024. PMID: 38923769 Free PMC article.
-
Use of proton pump inhibitors to treat persistent throat symptoms: multicentre, double blind, randomised, placebo controlled trial.BMJ. 2021 Jan 7;372:m4903. doi: 10.1136/bmj.m4903. BMJ. 2021. PMID: 33414239 Free PMC article. Clinical Trial.
-
Diagnosis of Laryngopharyngeal Reflux: Past, Present, and Future-A Mini-Review.Diagnostics (Basel). 2023 May 7;13(9):1643. doi: 10.3390/diagnostics13091643. Diagnostics (Basel). 2023. PMID: 37175034 Free PMC article. Review.
-
TOPPITS: Trial Of Proton Pump Inhibitors in Throat Symptoms. Study protocol for a randomised controlled trial.Trials. 2016 Apr 1;17:175. doi: 10.1186/s13063-016-1267-7. Trials. 2016. PMID: 27036555 Free PMC article. Clinical Trial.
MeSH terms
LinkOut - more resources
Full Text Sources